WILMINGTON, Del., July 1, 2016 /PRNewswire/ -- Last year, Falcon Capital Group achieved a 65.27% return on its Mid-Cap Fund and a 71.12% return on its Biotechnology Fund. Both numbers put the investment community on alert that the firm and its products are worth exploring. In fact, Falcon Capital has delivered over 50% returns annually since entering the market in 2008.
Falcon Capital's Biotechnology Fund outperformed up to 98% of all similar funds on the market in 2015. Fund Manager Thomas Evans selects large-, mid- and small-cap stocks that offer the best value, then holds those investments long enough to achieve price targets. With this approach, the fund has beaten industry benchmarks for five years running.
Long-term investment and steady growth is the aim of Falcon Capital's Mid-Cap Fund. Managed by Saul Bellard, the fund invests in mid-sized corporations around the world. Rather than chasing stocks from quarter to quarter, the Mid-Cap Fund emphasizes value and a global macroeconomic perspective. The fund's investments share several things in common, including above-average earnings growth and undervalued stock prices.
Falcon Capital offers investors a unique fund structure in which investors – not shareholders – own the funds. The firm charges no front-end purchase fees, sales commissions or marketing fees. The only cost to investors is a performance fee based entirely on fund profits, not principal. Falcon Capital endeavors to offer something for every type of investor, from income to long-term growth.
Current customers are pleased with Falcon Capital's consistent performance. Retiree Scott Hudock added the firm's funds to his retirement plan. Rob Yeaman was able to finance his children's education with Falcon Capital funds. "I've been a happy customer since 2010," says Adam Hammon, "and I recommend adding Falcon Capital funds to any portfolio, regardless of your investment goals."
Falcon Capital will soon introduce a new fund investing in gold and bitcoin. Brexit left the markets roiling in uncertainty, yet gold and bitcoin prices both saw healthy increases. Falcon Capital envisions this new fund as a hedge against the uncertainty that appears to be growing across international markets, while still maintaining the firm's core values of commitment, patience and superior research.
About Falcon Capital Group
Falcon Capital has been one of the best-kept secrets in the investing industry for 7 years. We are very proud of our outstanding record of benchmark-beating performance, and we want the world to know about it. Our new website reflects our values: commitment, patience and research. Our founders and fund managers all subscribe to empirically tested investment techniques based on quantitative research across all markets around the globe. We have found new and unique ways to reduce risk while increasing returns, and the results speak for themselves.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/falcon-capital-group-reports-exceptional-2015-performance-of-mid-cap-and-biotechnology-funds-300292971.html
SOURCE Falcon Capital Group